Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 30 (1) , 223-237
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas
- Cystic Fibrosis Foundation
- CIRM
This publication has 63 references indexed in Scilit:
- PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen ReceptorMolecular Therapy, 2011
- Intronic enhancers coordinate epithelial-specific looping of the active CFTR locusProceedings of the National Academy of Sciences, 2009
- CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway EpitheliumPLOS Biology, 2009
- Telomere length measurement by a novel monochrome multiplex quantitative PCR methodNucleic Acids Research, 2009
- Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Basal Cells of the Human Adult Airway Surface Epithelium Retain Transit-Amplifying Cell PropertiesStem Cells, 2006
- Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl−transport and overexpression can generate basolateral CFTRAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Analysis of Telomeres and TelomeraseCurrent Protocols in Cell Biology, 2003
- Telomerase Activity in Hematopoietic Cells Is Associated with Self-Renewal PotentialImmunity, 1996
- Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defectNature Genetics, 1995